Pharmacokinetic design optimization in children and estimation of maturation parameters: example of cytochrome P450 3A4

Author： Bouillon-Pichault Marion Jullien Vincent Bazzoli Caroline Pons Gérard Tod Michel

ISSN： 1567-567X

Source： Journal of Pharmacokinetics and Pharmacodynamics, Vol.38, Iss.1, 2011-02, pp. : 25-40

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacokinetic-Pharmacodynamic Consequences and Clinical Relevance of Cytochrome P450 3A4 Inhibition

By Dresser G.K.

Clinical Pharmacokinetics, Vol. 38, Iss. 1, 2000-01 ,pp. : 41-57

Adis International

Access to resources Recommend Favorite

Effect of Cytochrome P450 3A4 Inducers on the Pharmacokinetic, Pharmacodynamic and Safety Profiles of Bortezomib in Patients with Multiple Myeloma or Non-Hodgkin's Lymphoma

By Hellmann Andrzej

Clinical Pharmacokinetics, Vol. 50, Iss. 12, 2011-12 ,pp. : 781-791

Adis International

Access to resources Recommend Favorite

Comparison of Kinetic Parameters for Drug Oxidation Rates and Substrate Inhibition Potential Mediated by Cytochrome P450 3A4 and 3A5

Current Drug Metabolism, Vol. 9, Iss. 1, 2008-01 ,pp. : 20-33

Bentham Science Publishers

Access to resources Recommend Favorite

Mechanism-Based Inhibition of Cytochrome P450 3A4 by Therapeutic Drugs

By Zhou Shufeng

Clinical Pharmacokinetics, Vol. 44, Iss. 3, 2005-01 ,pp. : 279-304

Adis International

Access to resources Recommend Favorite

Cytochrome P450 3A and their regulation

By Burk Oliver Wojnowski Leszek

Naunyn-Schmiedeberg's Archives of Pharmacology, Vol. 369, Iss. 1, 2004-01 ,pp. : 105-124

Springer Publishing Company

Access to resources Recommend Favorite